SCHEMBL846092

SCHEMBL846092

CC(=O)c1cc(C(=O)O)cnc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.50
HCAR2 Q8TDS4 3/20 0.46
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 2/20 0.41
MGAM O43451 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
P4HA1 P13674 2/20 0.39
P4HTM Q9NXG6 2/20 0.39
TPMT P51580 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MIF P14174 1/20 0.38
POLB P06746 1/20 0.38
RAB9A P51151 1/20 0.38
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6052889 0.88 HCAR2 (0.48) HCAR2KDM4EALDH1A1ALOX15HSD17B10
SCHEMBL30668508 0.88 HCAR2 (0.48) HCAR2KDM4EALDH1A1ALOX15HSD17B10
Hydrochloric Acid SCHEMBL28615786 0.86 HCAR2 (0.47) HCAR2KDM4EALDH1A1ALOX15HSD17B10
SCHEMBL29952936 0.85 KDM4E (0.44) SMN1; SMN2HCAR2KDM4EALDH1A1KMT2A
Formamide SCHEMBL28252276 0.80 KDM4E (0.45) HCAR2KDM4EALDH1A1ALOX15HSD17B10
SCHEMBL2225177 0.79 HCAR2 (0.41) HCAR2KDM4EALDH1A1ALOX15HSD17B10
SCHEMBL6976830 0.79 HCAR2 (0.41) HCAR2KDM4EALDH1A1ALOX15HSD17B10
SCHEMBL2225183 0.79 HCAR2 (0.41) HCAR2KDM4EALDH1A1ALOX15HSD17B10
SCHEMBL6626587 0.78 SMN1; SMN2 (0.56) SMN1; SMN2HCAR2KDM4EALDH1A1HSD17B10
SCHEMBL846024 0.78 HCAR2 (0.50) HCAR2KDM4EALDH1A1ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200247798-A1 THERAPEUTIC AGENT FOR ANXIETY DISORDERS KYOWA KIRIN CO LTD (JP) 2020-08-06 US disclosed
US-10407440-B2 Therapeutic agent for motor disorders KYOWA HAKKO KIRIN CO., LTD. (JP) 2019-09-10 US disclosed
EP-3378860-A1 THERAPEUTIC AGENT FOR MOTOR DISORDERS Kyowa Hakko Kirin Co., Ltd. (JP) 2018-09-26 EP disclosed
EP-2433938-B1 THERAPEUTIC AGENT FOR MOTOR DISORDERS KYOWA HAKKO KIRIN CO LTD (JP) 2018-04-18 EP disclosed
US-20170275296-A1 THERAPEUTIC AGENT FOR MOTOR DISORDERS KYOWA KIRIN CO., LTD. (JP) 2017-09-28 US disclosed
US-9714257-B2 Therapeutic agent for motor disorders KYOWA HAKKO KIRIN CO., LTD. (JP) 2017-07-25 US disclosed
EP-2474544-B1 THERAPEUTIC AGENT FOR ANXIETY DISORDERS KYOWA HAKKO KIRIN CO LTD (JP) 2017-07-12 EP disclosed
EP-2474543-B1 THERAPEUTIC AGENT FOR MOOD DISORDERS KYOWA HAKKO KIRIN CO LTD (JP) 2017-05-03 EP disclosed
US-9249135-B2 Therapeutic agent for mood disorders KYOWA HAKKO KIRIN CO., LTD. (JP) 2016-02-02 US disclosed
US-20150225417-A1 THERAPEUTIC AGENT FOR MOTOR DISORDERS KYOWA KIRIN CO., LTD. (JP) 2015-08-13 US disclosed
CN-102414209-B Therapeutic agent for dyskinesia KYOWA HAKKO KIRIN CO LTD 2015-01-28 CN disclosed
US-20120184554-A1 THERAPEUTIC AGENT FOR MOOD DISORDERS KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-07-19 US disclosed
EP-2474543-A1 THERAPEUTIC AGENT FOR MOOD DISORDERS Kyowa Hakko Kirin Co., Ltd. (JP) 2012-07-11 EP disclosed
EP-2474544-A1 THERAPEUTIC AGENT FOR ANXIETY DISORDERS Kyowa Hakko Kirin Co., Ltd. (JP) 2012-07-11 EP disclosed
US-20120172362-A1 THERAPEUTIC AGENT FOR ANXIETY DISORDERS KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-07-05 US disclosed
CN-102482271-A Therapeutic agent for anxiety disorder KYOWA HAKKO KIRIN CO LTD 2012-05-30 CN disclosed
CN-102482272-A Therapeutic agent for mood disorders KYOWA HAKKO KIRIN CO LTD 2012-05-30 CN disclosed
US-20120101101-A1 THERAPEUTIC AGENT FOR MOTOR DISORDERS KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-04-26 US disclosed
CN-102414209-A Therapeutic agent for dyskinesia KYOWA HAKKO KIRIN CO LTD 2012-04-11 CN disclosed
EP-2433938-A1 THERAPEUTIC AGENT FOR MOTOR DISORDERS Kyowa Hakko Kirin Co., Ltd. (JP) 2012-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184554-A1 THERAPEUTIC AGENT FOR MOOD DISORDERS TPH1, HDAC1, HDAC2 SMN1; SMN2 4025/4885HCAR2 506/4885KDM4E 2195/4885
US-10407440-B2 Therapeutic agent for motor disorders DDT, COMT, SLC6A3 SMN1; SMN2 81/4885HCAR2 2081/4885KDM4E 4721/4885
US-20170275296-A1 THERAPEUTIC AGENT FOR MOTOR DISORDERS DDT, COMT, SLC6A3 SMN1; SMN2 81/4885HCAR2 2081/4885KDM4E 4721/4885
US-20120172362-A1 THERAPEUTIC AGENT FOR ANXIETY DISORDERS TAAR1, SLC6A1, GABBR1 SMN1; SMN2 3241/4885HCAR2 716/4885KDM4E 3799/4885
US-20120101101-A1 THERAPEUTIC AGENT FOR MOTOR DISORDERS DDT, COMT, SLC6A3 SMN1; SMN2 81/4885HCAR2 2081/4885KDM4E 4721/4885
US-20200247798-A1 THERAPEUTIC AGENT FOR ANXIETY DISORDERS TAAR1, SLC6A1, GABBR1 SMN1; SMN2 3241/4885HCAR2 716/4885KDM4E 3799/4885
US-20150225417-A1 THERAPEUTIC AGENT FOR MOTOR DISORDERS DDT, COMT, SLC6A3 SMN1; SMN2 81/4885HCAR2 2081/4885KDM4E 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.